Literature DB >> 33576919

Lack of information about umbilical cord blood banking leads to decreased donation rates among Brazilian pregnant women.

Helena Debiazi Zomer1,2, Ana Julia Girardi Gonçalves3, Jessica Andrade3, Aloisio Benedetti3,4, Andrea Gonçalves Trentin3,5.   

Abstract

The donation of umbilical cord blood (UCB) to public banks is essential to increase the probability of finding compatible donors for hematopoietic stem cell transplants. Brazil is currently the third-largest country in number of registered bone marrow donors, but it is far behind in terms of UCB donation. Thus, this questionnaire-based study aimed to assess Brazilian pregnant women's awareness, knowledge, beliefs, and opinions about UCB banking in order to identify the causes of low donation rates. Sixty-one percent of the responders were aware of UCB banking, but 86.9% of those declared to know little or very little about it. Only 14% of pregnant women were asked whether they would like to store or donate UCB. Just 13% have made a decision, and more than half decided not to donate or store it, with the leading cause being lack of knowledge. Finally, 94% of the responders believe that women should be told about UCB banking by their doctor before the last trimester of pregnancy. In conclusion, this study demonstrated that Brazilian pregnant women have insufficient knowledge about UCB banking, which affects their decision regarding UCB donation, and they wish to be better informed about it by health professionals.

Entities:  

Keywords:  Brazil; Hematopoietic stem cells; Questionnaire; Survey; Umbilical cord blood storage

Year:  2021        PMID: 33576919     DOI: 10.1007/s10561-021-09903-1

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  13 in total

1.  Ethical and legal aspects of placental/cord blood banking and transplant.

Authors:  E Gluckman
Journal:  Hematol J       Date:  2000

Review 2.  Family-directed umbilical cord blood banking.

Authors:  Eliane Gluckman; Annalisa Ruggeri; Vanderson Rocha; Etienne Baudoux; Michael Boo; Joanne Kurtzberg; Kathy Welte; Cristina Navarrete; Suzanna M van Walraven
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

3.  Knowledge about umbilical cord blood banking among Greek citizens.

Authors:  Louiza Z Karagiorgou; Maria-Nikoletta P Pantazopoulou; Nikolaos C Mainas; Apostolos I Beloukas; Anastasios G Kriebardis
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

4.  Evaluation of intracellular and extracellular trehalose as a cryoprotectant of stem cells obtained from umbilical cord blood.

Authors:  Juliana Pessanha Rodrigues Motta; Flávio Henrique Paraguassú-Braga; Luis Fernando Bouzas; Luís Cristóvão Porto
Journal:  Cryobiology       Date:  2014-04-21       Impact factor: 2.487

5.  Assessing women's knowledge and attitudes toward cord blood banking: policy and ethical implications for Jordan.

Authors:  Monica M Matsumoto; Rana Dajani; Yousef Khader; Kirstin R W Matthews
Journal:  Transfusion       Date:  2016-05-20       Impact factor: 3.157

6.  Latin America: the next region for haematopoietic transplant progress.

Authors:  G Jaimovich; J Martinez Rolon; H Baldomero; M Rivas; I Hanesman; L Bouzas; C Bonfim; J Palma; A Kardus-Urueta; D Ubidia; W Bujan-Boza; O Gonzalez-Ramella; G Ruiz-Argüelles; D Gomez-Almaguer; G Espino; E Fanilla; D Gonzalez; A Carrasco; S Galeano; G Borelli; M Hernandez-Gimenez; M Pasquini; Y Kodera; A Gratwohl; M Gratwohl; J Nuñez; J Szer; R P Gale; D Niederwieser; A Seber
Journal:  Bone Marrow Transplant       Date:  2017-01-23       Impact factor: 5.483

7.  Hematopoietic stem cell transplantation-50 years of evolution and future perspectives.

Authors:  Israel Henig; Tsila Zuckerman
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

8.  The law and problematic marketing by private umbilical cord blood banks.

Authors:  Blake Murdoch; Alessandro R Marcon; Timothy Caulfield
Journal:  BMC Med Ethics       Date:  2020-07-01       Impact factor: 2.652

9.  Plasma derived from human umbilical cord blood: Potential cell-additive or cell-substitute therapeutic for neurodegenerative diseases.

Authors:  Jared Ehrhart; Paul R Sanberg; Svitlana Garbuzova-Davis
Journal:  J Cell Mol Med       Date:  2018-10-18       Impact factor: 5.310

10.  Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Sueon Kim; Ji-Young Maeng; Seung-Joo Hyun; Hyun-Jung Sohn; Su-Yeon Kim; Cheol-Hwa Hong; Tai-Gyu Kim
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.